Helix BioMedix, Inc. (HXBM.OB) Reports First Quarter 2010 Financial Results
Helix BioMedix Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct classes and hundreds of thousands of peptide sequences. Applications for the company's peptides include anti-aging cosmeceutical skin care and acne treatment as well as other topical anti-infective pharmaceuticals and wound healing applications. The company today announced financial results for its first quarter 2010, which ended March 31, 2010. Revenue for the first quarter of 2010 was approximately $70,000 compared to revenue of about $87,000 in the prior year first quarter. Gross margin improved to 64.9% in the first quarter compared…